Got the Right Analyte? Versatile and Specific Diagnostics with LC-MS/MS
Zahraa Chorghay, PhD
From drug to newborn testing, quantitative analysis serves patients better
Mass Spectrometers
What’s New and Improved in Mass Spectrometry for Clinical Chemistry Testing?
Ian Black, MsComm, MSc
Thermo Fisher Scientific presents some of their latest technology regarding LC-MS
MALDI-TOF MS: An Evolving Tool in Clinical Diagnostics
Jake Moskowitz, DVM, PhD
Advances in MALDI-TOF MS have significantly expanded its use in high-throughput diagnostic labs
MALDI-TOF MS: An Evolving Approach to Cancer Profiling
Jake Moskowitz, DVM, PhD
New research suggests MALDI-TOF MS has an important place in the future of cancer diagnostics and therapeutics
An Innovative Year for Clinical Mass Spectrometry
María Rosales Gerpe, PhD
Highlights from the American Society for Mass Spectrometry and Allied Topics’s 69th conference
Beyond the Boundaries of LC-MS for Large Sample Proteomic Studies
Alexander Boychenko, PhD
Next-generation LC-MS technologies enable robust, high-quality proteome profiling
Advanced LC-MS Facilitates High-Throughput Metabolomics Research
Aaron Hudson, PhD
Liquid chromatography coupled with mass spectrometry is instrumental in metabolomics analyses
Analytical Sensitivity Holds Key to Successful Breath Analysis for Early Disease Detection
Dominic Roberts
Breath testing results reflect current metabolic activities, detecting changes that may occur before symptoms are evident
Innovation Drives a New Era of Clinical Testing
Jake Moskowitz, DVM, PhD
Disruptive technologies are changing the way we approach patient diagnostics and treatment
Infographic: The New Faces of Clinical Diagnostics
Jake Moskowitz, DVM, PhD
New testing platforms have the potential to transform clinical diagnostics and treatment